Toxicity of nanoparticles and an overview of current experimental models

Iranian Biomedical Journal

Volumn 20, Issue 1, 2016, Pages 1-11

  Bahadar, Haji ^a   Maqbool, Faheem ^a   Niaz, Kamal ^a   Abdollahi, Mohammad ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytotoxicity; In vitro; Metal nanoparticles; Review; Toxicology

Indexed keywords

ALUMINUM OXIDE NANOPARTICLE; CARBON NANOPARTICLE; COPPER OXIDE NANOPARTICLE; GOLD NANOPARTICLE; NANOPARTICLE; SILICA NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE; NANOMATERIAL;

APOPTOSIS; BLOOD BRAIN BARRIER; CELL STRUCTURE; CELL VIABILITY; CHROMOSOME DAMAGE; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA ADDUCT; DNA DAMAGE; DNA STRAND BREAKAGE; GENOTOXICITY; HUMAN; LIPID PEROXIDATION; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; ANIMAL; CELL LINE; CELL SURVIVAL; DRUG EFFECTS; PHYSIOLOGY; PROCEDURES; TRENDS;

ANIMALS; CELL LINE; CELL SURVIVAL; DNA DAMAGE; HUMANS; METAL NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY;

EID: 84944755075     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. De Berardis, B, Civitelli, G, Condello, M, Lista, P, Pozzi, R, Arancia, G and Meschini, S. Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol Appl Pharmacol 2010; 246: 116-127.
2. Nowrouzi, A, Meghrazi, K, Golmohammadi, T, Golestani, A, Ahmadian, S, Shafiezadeh, M, Shajary, Z, Khaghani, S and Amiri, AN. Cytotoxicity of subtoxic AgNP in human hepatoma cell line (HepG2) after longterm exposure. Iran Biomed J 2010; 14: 23-32.
3. De Jong, WH and Borm, PJ. Drug delivery and nanoparticles: applications and hazards. Intl J Nanomedicine 2008; 3: 133-149.
4. Lewinski, N, Colvin, V and Drezek, R. Cytotoxicity of nanoparticles. Small 2008; 4: 26-49.
5. Dreher, KL. Health and environmental impact of nanotechnology: Toxicological assessment of manufactured nanoparticles. Toxicol Sci 2004; 77: 3-5.
6. Oberdörster, G, Oberdörster, E and Oberdörster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113: 823-839.
7. Pourmand, A and Abdollahi, M. Current opinion on nanotoxicology. DARU 2012; 20: 95.
8. Vishwakarma, V, Samal, SS and Manoharan, N. Safety and risk associated with nanoparticles-a review. J Min Mat Charact Eng 2010; 9: 455.
9. Hagens, WI, Oomen, AG, de Jong, WH, Casse, FR and Sips, AJAM. What do we need to know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 2007; 49: 217-229.
10. Nemmar, A and Hoet, PH, Vanquickenborne, B, Dinsdale D, Thomeer, M, Hoylaerts, MF, Vanbilloen, H, Mortelmans, L, Nemery, B. Passage of inhaled particles into the blood circulation in humans. Circulation 2002; 105: 411-414.
11. Takenaka, S, Karg, E, Roth, C, Schulz, H, Ziesenis, A, Heinzmann, U, Schramel, P and Heyder, J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001; 109: 547-551.
12. Garnett, MC and Kallinteri, P. Nanomedicines and nanotoxicology: some physiological principles. Occup Med (Lond) 2006; 56: 307-311.
13. Yang, L and Watts, DJ. Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicol Lett. 2005; 158: 122-132.
14. Donaldson, K, Brown, D, Clouter, A, Duffin, R, MacNee, W, Renwick, L, Tran, L and Stone V. The pulmonary toxicology of ultrafine particles. J Aerosol Med 2002; 15: 213-220.
15. Mostafalou, S, Mohammadi, H, Ramazani, A and Abdollahi, M. Different biokinetics of nanomedicines linking to their toxicity; an overview. Daru 2013; 21: 14.
16. Chen, L, Yokel, RA, Hennig, B and Toborek, M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol 2008; 3: 286- 295.
17. Radziun, E, Dudkiewicz Wilczyńska J, Książek, I, Nowak, K, Anuszewska, EL, Kunicki A, Olszyna, A and Zabkowski, T. Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells. Toxicol In Vitro 2011; 25: 1694-1700.
18. 3 nanoparticles induce mitochondria-mediated cell death and upregulate the expression of signaling genes in human mesenchymal stem cells. J Biochem Mol Toxicol 2012; 26: 469-476.
19. Balasubramanyam, A, Sailaja, N, Mahboob, M, Rahman, MF, Hussain, SM and Grover, P. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis 2009; 24: 245-251.
20. 3) nanoparticle in mammalian cell lines. Mol Cell Toxicol 2009; 5: 172-178.
21. Jain, S, Hirst, DG and O'sullivan, JM. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 2012; 85: 101-113.
22. Connor, EE, Mwamuka, J, Gole, A, Murphy, CJ and Wyatt, MD. Gold Nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005; 1: 325-327.
23. Boisselier, E and Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009; 38: 1759- 1782.
24. Goodman, CM, Mccusker, CD, Yilmaz, T and Rotello, VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 2004 Jun; 15: 897-900.
25. Patra, HK, Banerjee, S, Chaudhuri, U, Lahiri, P and Dasgupta, AK. Cell selective response to gold nanoparticles. Nanomedicine 2007; 3: 111-119.
26. Aruoja, V, Dubourguier, HC, Kasemets, K and Kahru, A. Toxicity of nanoparticles of CuO, ZnO and TiO2 to microalgae Pseudokirchneriella subcapitata. Sci Total Environ 2009; 407: 1461-1468.
27. Lei, R, Wu, C, Yang, B, Ma, H, Shi, C, Wang, Q, Yuan Y and Liao M. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephro-toxicity in rats: A rapid in vivo screening method for nanotoxicity. Toxicol Appl Pharmacol 2008; 232: 292-301.
28. Chen, Z, Meng, H, Xing, G, Chen, C, Zhao, Y, Jia, G, Wang, T, Yuan, H, Ye, C, Zhao, F, Chai, Z, Zhu C, Fand X, Ma, B and Wan, L. Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett. 2006; 163: 109-120.
29. Meng, H, Chen, Z, Xing, G, Yuan, H, Chen, C, Zhao, F, Zhang, C, Zhao, Y. Ultrahigh reactivity provokes nanotoxicity: explanation of oral toxicity of nanocopper particles. Toxicol Lett 2007; 175: 102-110.
30. Ahamed, M, Siddiqui, MA, Akhtar, MJ, Ahmad, I, Pant, AB and Alhadlaq, HA. Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells. Biochem Biophy Res Commun 2010; 396: 578-583.
31. Chen, X and Schluesener, HJ. Nanosilver: A nanoproduct in medical application. Toxicol Lett 2008; 176: 1-12.
32. Tang, J, Xiong, L, Wang, S, Wang, J, Liu, L, Li, J, Yuan F and Xi, T. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 2009; 9: 4924-4932.
33. Hussain, SM, Hess, KL, Gearhart, JM, Geiss, KT and Schlager, JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In vitro 2005; 19: 975-983.
34. Foldbjerg, R, Dang, DA and Autrup, H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 2011; 85: 743- 750.
35. Haase, A, Tentschert, J, Jungnickel, H, Graf, P, Mantion, A, Draude, F, Plendl, J, Goetz, ME, Galla, S, Masic, A, Thuenemann, AF, Taubert, A, Arlinghaus, HF and Luch A. Toxicity of silver nanoparticles in human macrophages: uptake, intracellular distribution and cellular responses. J Physics 2011; 304: 012030.
36. Huang, GG, Wang, CT, Tang, HT, Huang, YS and Yang, J. ZnO nanoparticle-modified infrared internal reflection elements for selective detection of volatile organic compounds. Anal Chem 2006; 78: 2397-2404.
37. Huang, CC, Aronstam, RS, Chen, DR and Huang, YW. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol In Vitro 2010; 24: 45-55.
38. Sharma, V, Anderson, D and Dhawan, A. Zinc oxide nanoparticles induce oxidative DNA damage and ROStriggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 2012; 17: 852-70.
39. Brunner, TJ, Wick, P, Manser, P, Spohn, P, Grass, RN, Limbach, LK, Bruinink, A and Stark, WJ. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006; 40: 4374-4381.
40. Guan, R, Kang, T, Lu, F, Zhang, Z, Shen, H and Liu, M. Cytotoxicity, oxidative stress, and genotoxicity in human hepatocyte and embryonic kidney cells exposed to ZnO nanoparticles. Nanoscale Res Lett 2012; 7: 602- 7.
41. Meyer, K, Rajanahalli, P, Ahamed, M, Rowe, JJ and Hong, Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol In Vitro 2011; 25: 1721-1726.
42. Osman, IF, Baumgartner, A, Cemeli, E, Fletcher, JN and Anderson, D. Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells. Nanomedicine (Lond) 2010; 5: 1193-1203.
43. Sharma, V, Singh, P, Pandey, AK and Dhawan, A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mut Res 2012; 745: 84-91.
44. Naqvi, S, Samim, M, Abdin, M, Ahmed, FJ, Maitra, A, Prashant, C, Dinda, AK. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Intl J Nanomedicine 2010; 5: 983-989.
45. Albukhaty, S, Naderi-Manesh, H, Tiraihi, T. In vitro labeling of neural stem cells with poly-l-lysine coated super paramagnetic nanoparticles for green fluorescent protein transfection. Iran Biomed J 2013; 17: 71-6.
46. Liu, G, Gao, J, Ai, H, Chen, X. Applications and potential toxicity of magnetic iron oxide nanoparticles. Small 2013; 9: 1533-1545.
47. Zhu, MT, Feng, WY, Wang, B, Wang, TC, Gu, YQ, Wang, M, Wang, Y, Ouyang, H, Zhao, YL, Chai, ZF. Comparative study of pulmonary responses to nano- and submicron-sized ferric oxide in rats. Toxicology 2008; 247: 102-111.
48. Pawelczyk, E, Arbab, AS, Chaudhry, A, Balakumaran, A, Robey, PG, Frank, JA. In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells 2008; 26: 1366-1375.
49. Jeng, HA, Swanson, J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health Part A Tox Hazard Subst Environ Eng 2006; 41: 2699- 2711.
50. Ge, Y, Zhang, Y, He, S, Nie, F, Teng, G, Gu, N. Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging. Nanoscale Res Lett 2009; 4: 287-295.
51. Delcroix, GJ, Jacquart, M, Lemaire, L, Sindji, L, Franconi, F, Le Jeune, JJ, Montero-Menei CN. Mesenchymal and neural stem cells labeled with HEDPcoated SPIO nanoparticles: In vitro characterization and migration potential in rat brain. Brain Res 2009; 1255: 18-31.
52. Trouiller, B, Reliene, R, Westbrook, A, Solaimani, P, Schiestl, RH. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res 2009; 69: 8784-8789.
53. Liu, R, Yin, L, Pu, Y, Liang, G, Zhang, J, Su, Y, Xiao, Z, Ye, B. Pulmonary toxicity induced by three forms of titanium dioxide nanoparticles via intra-tracheal instillation in rats. Progress Nat Sci 2009; 19: 573-579.
54. Bhattacharya, K, Davoren, M, Boertz, J, Schins, R, Hoffmann, E, Dopp, E. Titanium dioxide nanoparticles induce oxidative stress and DNA-adduct formation but not DNA-breakage in human lung cells. Part Fibre Toxicol 2009; 6:17.
55. Liu, R, Zhang, X, Pu, Y, Yin, L, Li, Y, Zhang, X, Liang, G, Li, X, Zhang J. Small-sized titanium dioxide nanoparticles mediate immune toxicity in rat pulmonary alveolar macrophages in vivo. J Nanosci Nanotechnol 2010; 10: 5161-5169.
56. Liu, H, Ma, L, Zhao, J, Liu, J, Yan, J, Ruan, J, Hong, F. Biochemical toxicity of nano-anatase TiO2 particles in mice. Biol Trace Elem Res 2009; 129: 170-180.
57. Huczko A. Synthesis of aligned carbon nanotubes. Appl Phys 2001; 74: 617-638.
58. Magrez, A, Kasas, S, Salicio, V, Pasquier, N, Seo, JW, Celio, M, Catsicas, S, Schwaller, B, Forro L. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006; 6: 1121-1125.
59. Herzog, E, Casey, A, Lyng, FM, Chambers, G, Byrne, HJ, Davoren, M. A new approach to the toxicity testing of carbon-based nanomaterials the clonogenic assay. Toxicol Lett 2007; 174: 49-60.
60. Poland, CA, Duffin, R, Kinloch, I, Maynard, A, Wallace, WA, Seaton, A, Stone, V, Brown, S, Macnee, W, Donaldson, K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008; 3: 423-428.
61. Yang ST, Wang X, Jia G, Gu Y, Wang, T, Nie, H, Ge, C, Wang, H, Liu, Y. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol Lett. 2008; 181: 182-189.
62. Donaldson, K, Aitken, R, Tran, L, Stone, V, Duffin, R, Forrest, G, Alexander, A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci. 2006; 92: 5-22.
63. Pulskamp, K, Diabaté, S, Krug, HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007; 168: 58-74.
64. Qingnuan, L, Yan, X, Xiaodong, Z, Ruili, L, Qieqie, D, Xiaoguang, S, Shaoliang, C, Wenxin, L. Preparation of (99m) Tc-C (60)(OH)(x) and its biodistribution studies. Nucl Med Biol. 2002; 29: 707-710.
65. Kobayashi, K, Kuwano, M, Sueki, K, Kikuchi, K, Achiba, Y, Nakahara, H, Kananishi, N, Watanabe, M, Tomura, K. Activation and tracer techniques for study of metallofullerenes. J Radioanal Nucl Chem. 2005; 192: 81-89.
66. Cagle, DW, Kennel, SJ, Mirzadeh, S, Alford, JM, Wilson, LJ. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers. Proc Natl Acad Sci USA 1999; 96: 5182-5187.
67. Dhawan, A, Taurozzi, JS, Pandey, AK, Shan, W, Miller, SM, Hashsham, SA, Tarabara, VV. Stable colloidal dispersions of C60 fullerenes in water: evidence for genotoxicity. Environ Sci Technol. 2006; 40: 7394-401.
68. Niwa, Y, Iwai, N. Genotoxicity in cell lines induced by chronic exposure to water-soluble fullerenes using micronucleus test. Environ Health Prev Med 2006; 11: 292-297.
69. Jacobsen, NR, Pojana, G, White, P, Moller, P, Cohn, CA, Korsholm, KS, Vogel, U, Marcomini, A, Loft, S, Wallin, H. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Mutatrade markMouse lung epithelial cells. Environ Mol Mutagen. 2008; 49: 476-487.
70. Wilczewska, AZ, Niemirowicz, K, Markiewicz, KH, Car, H. Nanoparticles as drug delivery systems. Pharmacol Rep 2012; 64: 1020-1037.
71. Balduzzi, M, Diociaiuti, M, De Berardis, B, Paradisi, S, Paoletti, L. In vitro effects on macrophages induced by noncytotoxic doses of silica particles possibly relevant to ambient exposure. Environ Res 2004; 96: 62-71.
72. Park, EJ, Park K. Oxidative stress and pro-inflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett 2009; 184: 18-25.
73. Lin, W, Huang, YW, Zhou, XD, Ma, Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 2006; 217:252-259.
74. Cho, M, Cho, WS, Choi, M, Kim, SJ, Han, BS, Kim, SH, Kim, HO, Sheen, YY, Jeong, J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009; 189: 177-183.
75. Cho, WS, Choi, M, Han, BS, Cho, M, Oh, J, Park, K, Kim, SJ, Kim, SH, Jeong, J. Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett 2007; 175: 24- 33.
76. Sun, L, Li, Y, Liu, X, Jin, M, Zhang, L, Du, Z, Guo, C, Huang, P, Sun, Z. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol In Vitro. 2011; 25: 1619-1629.
77. Nishimori, H, Kondoh, M, Isoda, K, Tsunoda, S, Tsutsumi, Y, Yagi, K. Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 2009; 72: 496- 501.
78. Panyam, J, Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329-347.
79. Grabowski, N, Hillaireau, H, Vergnaud, J, Tsapis, N, Pallardy, M, Kerdine-Röme, S, Fattal, E. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages. Intl J Pharm 2015 Mar; 482: 75-83.
80. Pisanic TR, Blackwell JD, Shubayev VI, Fiñones RR, Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007 Jun; 28: 2572-2581.
81. Gal-Edd, GS, N Arkin, M. Auld D. Austin C. Bejcek B. Glicksman M. Inglese J. Lemmon and V. Li Z, Cell Viability Assays. In: Assay Guidance Manual, Bethesda (MD); 2004.
82. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55- 63.
83. Monteiro-Riviere, NA, Inman, AO, Zhang, LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009; 234: 222-235.
84. Plumb, JA, Milroy, R, Kaye, SB. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2, 5- diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazoliumbased assay. Cancer Res 1989; 49: 4435-4440.
85. Granchi, D, Ciapetti, G, Savarino, L, Cavedagna, D, Donati, ME, Pizzoferrato, A. Assessment of metal extract toxicity on human lymphocytes cultured in vitro. J Biomed Mat Res 1996; 31: 183-191.
86. Moe, B, Gabos, S, Li, XF. Real-time cellmicroelectronic sensing of nanoparticle-induced cytotoxic effects. Anal Chim Acta 2013; 789: 83-90.
87. Davis, RR, Lockwood, PE, Hobbs, DT, Messer, RJ, Price, RJ, Lewis, JB, Wataha, JC. In vitro biological effects of sodium titanate materials. J Biomed Mater Res B App Biomater 2007; 83: 505-511.
88. Kroll, A, Pillukat, MH, Hahn, D, Schnekenburger, J. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur J Pharm Biopharm 2009; 72: 370-377.
89. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 64: 313-320.
90. Sayes, CM, Reed, KL, Warheit, DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007; 97: 163-180.
91. Yacobi, NR, Phuleria, HC, Demaio, L, Liang, CH, Peng, CA, Sioutas, C, Borok, K, Kim, KJ, Crandall, ED. Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties. Toxicol In Vitro 2007; 21: 1373-1381.
92. Roberts, JE, Wielgus, AR, Boyes, WK, Andley, U, Chignell, CF. Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells. Toxicol Appl Pharmacol 2008; 228: 49-58.
93. Lison, D, Thomassen, LC, Rabolli, V, Gonzalez, L, Napierska, D, Seo, JW, Kirsch-Volders, M, Hoet, P, Kirschhock, CE, Martens, JA. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol Sci 2008; 104: 155-162.
94. Nachlas MM, Margulies SI, Goldberg JD, Seligman AM. The determination of lactic dehydrogenase with a tetrazolium salt. Anal Biochem 1960; 1: 317-326.
95. Suska, F, Gretzer, C, Esposito, M, Tengvall, P, Thomsen, P. Monocyte viability on titanium and copper coated titanium. Biomaterials 2005; 26: 5942-5950.
96. Oberdörster, G, Maynard, A, Donaldson, K, Castranova, V, Fitzpatrick, J, Ausman, K, Carter, J, Karn, B, Kreyling, W, Lai, D, Olin, S, Monteiro-Riviere, N, Warheit, D, Yang, H, ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005; 2: 8.
97. Schulze, C, Kroll, A, Lehr, CM, Schäfer, UF, Becker, K, Schnekenburger, J, Isfort, CS, Landsiedel, R, Wohlleben, W. Not ready to use-overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2015; 2: 51-61.
98. Donaldson, K, Borm, P, Castranova, V, Gulumian, M. The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles. Part Fibre Toxicol 2009; 6: 13.
99. Shetab-Boushehri, SV, Abdollahi, M. Current concerns on the validity of in vitro models that use transformed neoplastic cells in pharmacology and toxicology. Int J Pharmacol 2012; 8: 594-595.
100. Liu, LP, Xiao, YB, Xiao, ZW, Wang, ZB, Li, C, Gong, X. Toxicity of hydroxyapatite nanoparticles on rabbits. Wei Sheng Yan Jiu 2005; 34: 474-476.
101. Bagher, Z, Rajaei, F, Shokrgoza, M. Comparative study of bone repair using porous hydroxyapatite/β-tricalcium phosphate and xenograft scaffold in rabbits with tibia defect. Iran Biomed J 2012; 16: 18-24.